Structure elucidation plays an essential role in understanding the fundamental biology of diseases and in discovering and developing novel therapies to improve human health. In recent years, there have been substantial research efforts to develop new therapies to tackle disease areas where traditional small molecules and large molecules have had their limitations. These new modalities include peptides, oligonucleotides, macrocycles, polymer drug conjugates, antibody/bispecific antibody drug conjugates, and many others. With the increasing complexity of small molecules, large molecules and new modalities, the success of structure elucidation requires an array of complementary analytical technologies rather than a particular one. Additionally, new analytical technologies will need to be developed. This conference will highlight major developments in analytical technologies and applications in core areas of structure elucidation and biological function. Furthermore, the conference will bring the best researchers from academia, analytical instrument and pharmaceutical industries. The conference's aim is to encourage collaborations between the industry and academia with the ultimate goal to transform fundamental science into meaningful therapeutics.
The conference will consist of nine sessions, on the topics listed below. The conference chair is currently developing their preliminary program, which will include the names of the invited speakers and discussion leaders for each of these sessions. The preliminary program will be available by October 15, 2019. Please check back for updates.
- Keynote Session: Biomolecular Processes
- Analytical Characterization of New Modalities
- High Throughput Experimentation, Computational Chemistry and Machine Learning
- NMR and Other Spectroscopic Techniques
- Emerging Techniques in Separation Science
- Advancing Pharmaceutical Discovery and Development Through Molecular Structure Elucidation
- The Dark Metabolome
- Proteins in Unusual States
- Efficient Development of Novel Analytical Technologies via Collaborations Between Academia and the Pharmaceutical Industry